These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18436799)

  • 1. Arginine and arginase: endothelial NO synthase double crossed?
    Vanhoutte PM
    Circ Res; 2008 Apr; 102(8):866-8. PubMed ID: 18436799
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiochemical high-performance liquid chromatography detection of arginine metabolism in human endothelial cells.
    Barilli A; Visigalli R; Rotoli BM; Bussolati O; Gazzola GC; Parolari A; Dall'Asta V
    Anal Biochem; 2012 May; 424(2):156-61. PubMed ID: 22381370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow J; Jung C
    Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial arginase II: a novel target for the treatment of atherosclerosis.
    Ryoo S; Gupta G; Benjo A; Lim HK; Camara A; Sikka G; Lim HK; Sohi J; Santhanam L; Soucy K; Tuday E; Baraban E; Ilies M; Gerstenblith G; Nyhan D; Shoukas A; Christianson DW; Alp NJ; Champion HC; Huso D; Berkowitz DE
    Circ Res; 2008 Apr; 102(8):923-32. PubMed ID: 18309100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
    Durante W; Johnson FK; Johnson RA
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells.
    Mammedova JT; Sokolov AV; Freidlin IS; Starikova EA
    Biochemistry (Mosc); 2021 Feb; 86(2):146-155. PubMed ID: 33832413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roads to dysfunction: argininase II contributes to oxidized low-density lipoprotein-induced attenuation of endothelial NO production.
    Brandes RP
    Circ Res; 2006 Oct; 99(9):918-20. PubMed ID: 17068298
    [No Abstract]   [Full Text] [Related]  

  • 8. Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis.
    Rabelo LA; Ferreira FO; Nunes-Souza V; da Fonseca LJ; Goulart MO
    Oxid Med Cell Longev; 2015; 2015():924860. PubMed ID: 26064427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
    Sezgin N; Torun T; Yalcin F
    Med Sci Monit; 2002 Oct; 8(10):LE44. PubMed ID: 12434793
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemical HPLC detection of arginine metabolism: measurement of nitric oxide synthesis and arginase activity in vascular tissue.
    de Bono JP; Warrick N; Bendall JK; Channon KM; Alp NJ
    Nitric Oxide; 2007 Feb; 16(1):1-9. PubMed ID: 16647284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and molecular mechanisms of endothelial cell dysfunction.
    Harrison DG
    J Clin Invest; 1997 Nov; 100(9):2153-7. PubMed ID: 9410891
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of arginine-nitric oxide pathway in patients with Alzheimer disease.
    Vural H; Sirin B; Yilmaz N; Eren I; Delibas N
    Biol Trace Elem Res; 2009; 129(1-3):58-64. PubMed ID: 19099206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].
    Pokrovskiĭ MV; Pokrovskaia TG; Kochkarov VI; Artiushkova EB
    Eksp Klin Farmakol; 2008; 71(2):29-31. PubMed ID: 18488903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating SIRT1: a new strategy to prevent atherosclerosis?
    Brandes RP
    Cardiovasc Res; 2008 Nov; 80(2):163-4. PubMed ID: 18784217
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peculiarities of L-arginine metabolism in the blood leukocytes in experimental diabetes mellitus].
    Brodiak IV; Sybirna NO
    Fiziol Zh (1994); 2008; 54(1):63-8. PubMed ID: 18416186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose 6-P Dehydrogenase Overexpression Improves Aging-Induced Endothelial Dysfunction in Aorta from Mice: Role of Arginase II.
    Serna E; Mauricio MD; San-Miguel T; Guerra-Ojeda S; Verdú D; Valls A; Arc-Chagnaud C; De la Rosa A; Viña J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New functional aspects of the L-arginine-nitric oxide metabolism within the circulating blood.
    Kleinbongard P; Keymel S; Kelm M
    Thromb Haemost; 2007 Nov; 98(5):970-4. PubMed ID: 18000600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine/arginase NO NO NO.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):237-9. PubMed ID: 16424360
    [No Abstract]   [Full Text] [Related]  

  • 20. In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells.
    Montañez R; Rodríguez-Caso C; Sánchez-Jiménez F; Medina MA
    Amino Acids; 2008 Feb; 34(2):223-9. PubMed ID: 17520329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.